Conflicting results were reported in invasive breast cancer specimens, where high TUBB3 expression was identified in both ER positive and ER negative breast tumour specimens (Wang et al., 2013), raising the question as to whether ER is relevant to TUBB3 regulation in the clinic. Here, TUBB3 is linked to invasive breast carcinoma.